This page includes the profile as well as useful links and contact information for the state of Maryland. If you find any missing or out of date information please contact us.
The Office of Provider Engagement & Regulations (OPER) consists of the Office of Controlled Substances Administration (OCSA) and the Prescription Drug Monitoring Program (PDMP). OCSA is focused on protecting the health and safety of the citizens of Maryland by enforcing the Controlled Dangerous Substances Act. This ensures that controlled dangerous substances (CDS) are available for legitimate medical and scientific purposes and prevents drug abuse and diversion. To carry out its mission OCSA activities include: Registration of all persons that administer, prescribe, dispense, distribute, manufacture, conduct research and conduct chemical analysis of CDS.
|Collection Agency:||RX GOV|
|ASAP Version:||ASAP 4.2|
|Zero Reporting Required:||YES|
|Zero Reporting Period:||1 day|
|Veterinary Clinic Reporting Required:||NO|